Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Hansen

Showing results (151-160 of 178) with videos related to

Pageof 18
Sort By:
Cardiovascular Diagnosis and Therapy|January 24, 2022
Outcome of pregnancy in a contemporary cohort of adults with congenital heart disease-a 10-year, single-center experienceBetül Toprak, Katharina Govorov, Katinka Kurz, et al.
Oncotarget|November 5, 2017
Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastasesOlga Østrup, Vegar Johansen Dagenborg, Einar Andreas Rødland, et al.
Physics and Imaging in Radiation Oncology|January 31, 2023
Imaging the tumour microenvironment in rectal cancer: Decline in tumour blood flow during radiotherapy predicts good outcomeKine Mari Bakke, Sebastian Meltzer, Endre Grøvik, et al.
Pharmacoepidemiology and Drug Safety|August 15, 2015
Antiepileptic drug prescribing before, during and after pregnancy: a study in seven European regionsRachel Charlton, Ester Garne, Hao Wang, et al.
European Heart Journal|February 24, 2016
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprololGeeta Gulati, Siri Lagethon Heck, Anne Hansen Ree, et al.
British Journal of Cancer|April 10, 2021
The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancerSebastian Meltzer, Annette Torgunrud, Hanna Abrahamsson, et al.
Frontiers in Oncology|February 11, 2025
Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolismMarte Svalastoga, Trine-Lise Larsen, Jorunn Brekke, et al.
Acta Oncologica (Stockholm, Sweden)|December 17, 2021
MRI-based automatic segmentation of rectal cancer using 2D U-Net on two independent cohortsFranziska Knuth, Ingvild Askim Adde, Bao Ngoc Huynh, et al.
Thrombosis Research|September 12, 2020
Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolismTrine-Lise Hannevik, Jorunn Brekke, Tone Enden, et al.
Journal of Thrombosis and Haemostasis : JTH|July 21, 2022
"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up": ReplyTrine-Lise Larsen, Herish Garresori, Jorunn Brekke, et al.
Pageof 18

Showing results (151-160 of 178) with videos related to

Sort By:
Pageof 18
Cardiovascular Diagnosis and Therapy|January 24, 2022
Outcome of pregnancy in a contemporary cohort of adults with congenital heart disease-a 10-year, single-center experienceBetül Toprak, Katharina Govorov, Katinka Kurz, et al.
Oncotarget|November 5, 2017
Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastasesOlga Østrup, Vegar Johansen Dagenborg, Einar Andreas Rødland, et al.
Physics and Imaging in Radiation Oncology|January 31, 2023
Imaging the tumour microenvironment in rectal cancer: Decline in tumour blood flow during radiotherapy predicts good outcomeKine Mari Bakke, Sebastian Meltzer, Endre Grøvik, et al.
Pharmacoepidemiology and Drug Safety|August 15, 2015
Antiepileptic drug prescribing before, during and after pregnancy: a study in seven European regionsRachel Charlton, Ester Garne, Hao Wang, et al.
European Heart Journal|February 24, 2016
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprololGeeta Gulati, Siri Lagethon Heck, Anne Hansen Ree, et al.
British Journal of Cancer|April 10, 2021
The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancerSebastian Meltzer, Annette Torgunrud, Hanna Abrahamsson, et al.
Frontiers in Oncology|February 11, 2025
Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolismMarte Svalastoga, Trine-Lise Larsen, Jorunn Brekke, et al.
Acta Oncologica (Stockholm, Sweden)|December 17, 2021
MRI-based automatic segmentation of rectal cancer using 2D U-Net on two independent cohortsFranziska Knuth, Ingvild Askim Adde, Bao Ngoc Huynh, et al.
Thrombosis Research|September 12, 2020
Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolismTrine-Lise Hannevik, Jorunn Brekke, Tone Enden, et al.
Journal of Thrombosis and Haemostasis : JTH|July 21, 2022
"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up": ReplyTrine-Lise Larsen, Herish Garresori, Jorunn Brekke, et al.
Pageof 18